课题基金 / 基金详情

Regulation of Nephron Progenitor Cell Self-Renewal and Differentiation

Regulation of Nephron Progenitor Cell Self-Renewal and Differentiation
肾单位祖细胞自我更新和分化的调节
批准号:
8638282
负责人:
MICHAEL I RAUCHMAN
金额:
$32.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-07 至 2018-04-30

项目摘要

项目成果

MICHAEL I RAUCHMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT The long-term goal of the proposed work is to determine how the Sall1 transcription factor and its associated chromatin remodeling complexes control gene regulation to generate a normal endowment of nephrons. This will illuminate mechanisms that underlie human genetic syndromes and common sporadic birth defects, such as renal hypoplasia (small kidneys with reduced numbers of nephrons), which result in kidney failure. Formation of the proper complement of nephrons requires a balance between expansion of multi-potent renal progenitor cells and differentiation. Genetic deficiency of Sall1 alters gene expression in the developing kidney, accelerating nephron differentiation leading to a depletion of nephron progenitor cells and renal hypoplasia. These uncommitted nephron precursors, termed cap mesenchyme, must respond to canonical Wnt/ss-catenin signals by either undergoing self-renewal or mesenchymal-to-epithelial transition to form most tubular segments of the nephron. The transcriptional mechanisms that control these opposing responses of the cap mesenchyme are not known, but current evidence argues that Sall1 is pivotal in this critical developmental decision. Our recent studies provide evidence for a novel paradigm. We propose that Sall1 cooperates with the Nucleosome Remodeling and Deacetylase (NuRD) chromatin remodeling complex, to determine nephron progenitor cell fate by regulating the transcriptional output in response to Wnt/ss-catenin. This application will test key predictions of this model using a combination of genetic, genomic, and biochemical approaches. Six2 is an inhibitor of nephron differentiation. In Aim 1, we will determine if Sall1 directly up-regulates Six2 expression in cap mesenchyme to restrain differentiation of progenitor cells. Expression of Wnt9b, the main differentiation signal, is increased in Sall1 mutants. We will determine if the combination of increased Wnt9b and reduced Six2 expression are sufficient to cause accelerated nephron formation, and exhaustion of self-renewing progenitor cells. Aim 2 will determine how Sall1 and NuRD control the transcriptional output in nephron progenitor cells to determine whether the uncommitted precursor cells undergo self-renewal or initiate nephron differentiation. The mechanistic insights gained from these studies will advance efforts to propagate nephron progenitors in vitro and/or promote regeneration of mature tubular epithelial cells in order to correct nephron deficits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Project 2: Molecular analysis of developing post-natal mouse kidney in health and FSGS
  • 批准号:
    10530271
  • 项目类别:
  • 资助金额:
    $21.88万
  • 财政年份:
    2022
  • 负责人:
    MICHAEL I RAUCHMAN
  • 依托单位:
Research Project 2: Molecular analysis of developing post-natal mouse kidney in health and FSGS
  • 批准号:
    10707966
  • 项目类别:
  • 资助金额:
    $19.3万
  • 财政年份:
    2022
  • 负责人:
    MICHAEL I RAUCHMAN
  • 依托单位:
Single Cell Chromatin Profiling in Kidney Tissue
  • 批准号:
    10373426
  • 项目类别:
  • 资助金额:
    $23.63万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL I RAUCHMAN
  • 依托单位:
Epigenetic mechanisms of gene regulation in nephron progenitor cell proliferation and differentiation
  • 批准号:
    10289761
  • 项目类别:
  • 资助金额:
    $42.22万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL I RAUCHMAN
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: